journal article·2026-03Open access

A Non‐Mitophagy Activity of BNIP3L/NIX in Amygdala Glutamatergic Neurons is Essential for Contextual Fear Memory Formation

Xingxian Zhang, Xinlei Mo, Xinyu Zhou, Xiaoliang Liu, Guizhi Li, Songhui Hu, Yangyang Lu, Chenze Zhu, Jinxi Feng, Zhitong Chen, Weiwei Hu, Yihui Cui, Zhong Chen, Xiangnan Zhang

Advanced Science· Volume 13· Issue 18

Abstract

ABSTRACT Mitochondrial quality is crucial for maintaining brain homeostasis. BNIP3L/NIX, a mitophagy receptor, has been linked to neurological disorders, yet its specific function in the brain remains unclear. We found BNIP3L highly expressed in basolateral amygdala (BLA) neurons. Selective deletion of bnip3l in BLA glutamatergic neurons (BLA GLU ) impaired contextual fear memory, accompanied by reduced neuronal excitation and mitochondrial respiration. Notably, fear conditioning did not invariably activate mitophagy in BLA GLU neurons. Overexpression of both wild‐type and a mitophagy‐deficient mutant (BNIP3L ΔLIR ) in BLA GLU neurons was sufficient to rescue the contextual fear memory deficits in bnip3l −/− mice, suggesting a non‐mitophagy role. Instead, we detected a prompt mitochondrial fission in BLA GLU neurons after foot‐shock conditioning, an effect abolished by bnip3l deletion. Inhibition of Drp1 with Mdivi‐1 disrupted memory formation, whereas optogenetic activation of Drp1 restored neuronal excitation and rescued memory deficits in bnip3l −/− mice. These data indicated an essential role of BNIP3L‐mediated mitochondrial fission in modulating contextual fear memory. Mechanistically, BNIP3L and Drp1 competitively interact with AMPK, leading to reduced Drp1 phosphorylation and increased Drp1 accumulation on mitochondria, thereby promoting mitochondrial fission. Taken together, the present study revealed a previously uncharacterized, non‐mitophagy‐dependent role for BNIP3L in contextual fear memory conditioning.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Autophagy in Disease and Therapy · Neuroscience and Neuropharmacology Research · Alzheimer's disease research and treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Pharmacology & Toxicology Zhejiang Key Laboratory of Neuropsychopharmacology State Key Laboratory of Advanced Drug Delivery and Release Systems College of Pharmaceutical Sciences Zhejiang University Hangzhou China

School of Pharmacy Hangzhou Medical College Hangzhou Zhejiang China

Jinhua Institute of Zhejiang University Jinhua Zhejiang China

Department of Pharmacology and Department of Pharmacy of the Second Affiliated Hospital School of Basic Medical Sciences Zhejiang University Hangzhou Zhejiang China

Department of Neurobiology Department of Neurology of Sir Run Run Shaw Hospital Zhejiang University School of Medicine Hangzhou Zhejiang China

Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province College of Pharmaceutical Sciences Zhejiang Chinese Medical University Hangzhou Zhejiang China

Funding

Key Research and Development Program of Zhejiang Province · National Natural Science Foundation of China

References (82)

Show source-provided references
1. 10.1016/j.nbd.2015.10.01110.1016/j.nbd.2015.10.011 ↗
2. 10.1016/j.cell.2004.11.00310.1016/j.cell.2004.11.003 ↗
3. 10.1073/pnas.071218010510.1073/pnas.0712180105 ↗
4. 10.1038/cddis.2015.9410.1038/cddis.2015.94 ↗
5. 10.1038/s42255-020-00289-010.1038/s42255-020-00289-0 ↗
6. 10.1038/s41467-018-07416-210.1038/s41467-018-07416-2 ↗
7. 10.1016/j.neuron.2024.03.01310.1016/j.neuron.2024.03.013 ↗
8. 10.1038/srep3146210.1038/srep31462 ↗
9. 10.1083/jcb.20070411010.1083/jcb.200704110 ↗
10. 10.1016/j.jmb.2019.10.01510.1016/j.jmb.2019.10.015 ↗
11. 10.1038/s41556-024-01513-910.1038/s41556-024-01513-9 ↗
12. 10.1073/pnas.040959810210.1073/pnas.0409598102 ↗
13. 10.1111/cns.1232510.1111/cns.12325 ↗
14. 10.1083/jcb.20080912510.1083/jcb.200809125 ↗
15. 10.1007/s10059-012-0051-010.1007/s10059-012-0051-0 ↗
16. 10.1038/embor.2009.25610.1038/embor.2009.256 ↗
17. 10.1073/pnas.070881810410.1073/pnas.0708818104 ↗
18. 10.1038/nature0700610.1038/nature07006 ↗
19. 10.1080/15548627.2020.175512010.1080/15548627.2020.1755120 ↗
20. 10.1038/s41380-023-02008-z10.1038/s41380-023-02008-z ↗
21. 10.1186/s40246-020-00266-410.1186/s40246-020-00266-4 ↗
22. 10.1152/ajprenal.00360.201810.1152/ajprenal.00360.2018 ↗
23. 10.1016/j.celrep.2021.10868910.1016/j.celrep.2021.108689 ↗
24. 10.1080/15548627.2020.187120410.1080/15548627.2020.1871204 ↗
25. 10.1038/nn.386910.1038/nn.3869 ↗
26. 10.1152/physrev.00037.200910.1152/physrev.00037.2009 ↗
27. 10.1038/nature1418810.1038/nature14188 ↗
28. 10.1038/s41380-022-01765-710.1038/s41380-022-01765-7 ↗
29. 10.1016/S2215-0366(16)30358-310.1016/S2215-0366(16)30358-3 ↗
30. 10.1007/s11920-020-1140-y10.1007/s11920-020-1140-y ↗
31. 10.1038/s41593-025-02025-x10.1038/s41593-025-02025-x ↗
32. 10.1038/s41467-021-22911-910.1038/s41467-021-22911-9 ↗
33. 10.1038/s41593-023-01469-310.1038/s41593-023-01469-3 ↗
34. 10.1016/j.neuropharm.2010.11.00610.1016/j.neuropharm.2010.11.006 ↗
35. 10.1038/s41593-021-00856-y10.1038/s41593-021-00856-y ↗
36. 10.1016/j.biopsych.2021.12.01810.1016/j.biopsych.2021.12.018 ↗
37. 10.1038/s41467-020-20679-y10.1038/s41467-020-20679-y ↗
38. 10.1172/JCI17199510.1172/JCI171995 ↗
39. 10.1016/j.neuron.2021.09.00810.1016/j.neuron.2021.09.008 ↗
40. 10.1080/15548627.2020.180208910.1080/15548627.2020.1802089 ↗
41. 10.1080/15548627.2017.135779210.1080/15548627.2017.1357792 ↗
42. 10.1038/s41598-017-01258-610.1038/s41598-017-01258-6 ↗
43. 10.4161/auto.2076410.4161/auto.20764 ↗
44. 10.15252/embj.202311349110.15252/embj.2023113491 ↗
45. 10.1002/2211-5463.1330710.1002/2211-5463.13307 ↗
46. 10.1016/j.neuron.2019.11.02010.1016/j.neuron.2019.11.020 ↗
47. 10.1038/s41583-021-00535-810.1038/s41583-021-00535-8 ↗
48. 10.1038/s41598-023-40877-010.1038/s41598-023-40877-0 ↗
49. 10.1038/s41586-021-03510-610.1038/s41586-021-03510-6 ↗
50. 10.1126/science.116392710.1126/science.1163927 ↗
51. 10.1038/s41380-021-01038-910.1038/s41380-021-01038-9 ↗
52. Fonseca T. B. · Mitochondrial fission requires DRP1 but not dynamins · 2019 · 570 · E34
53. 10.1111/j.1749-6632.2010.05629.x10.1111/j.1749-6632.2010.05629.x ↗
54. 10.1038/s41401-020-00518-y10.1038/s41401-020-00518-y ↗
55. 10.1038/s41392-020-0151-910.1038/s41392-020-0151-9 ↗
56. 10.1080/15548627.2017.133256710.1080/15548627.2017.1332567 ↗
57. 10.1038/nm71910.1038/nm719 ↗
58. 10.1161/CIRCULATIONAHA.107.72707310.1161/CIRCULATIONAHA.107.727073 ↗
59. 10.4161/auto.555210.4161/auto.5552 ↗
60. 10.1038/s41401-018-0077-810.1038/s41401-018-0077-8 ↗
61. 10.1038/s42003-024-07105-510.1038/s42003-024-07105-5 ↗
62. 10.1523/JNEUROSCI.15-03-02312.199510.1523/JNEUROSCI.15-03-02312.1995 ↗
63. 10.1037/0735-7044.108.1.21010.1037/0735-7044.108.1.210 ↗
64. 10.1523/JNEUROSCI.10-04-01062.199010.1523/JNEUROSCI.10-04-01062.1990 ↗
65. 10.1523/JNEUROSCI.22-12-05219.200210.1523/JNEUROSCI.22-12-05219.2002 ↗
66. 10.1113/jphysiol.2014.27771510.1113/jphysiol.2014.277715 ↗
67. 10.1038/nrn.2017.17010.1038/nrn.2017.170 ↗
68. 10.1016/j.biopsych.2017.10.00610.1016/j.biopsych.2017.10.006 ↗
69. 10.3389/fncir.2013.0012910.3389/fncir.2013.00129 ↗
70. 10.1038/s41593-019-0528-710.1038/s41593-019-0528-7 ↗
71. 10.1038/s41467-020-17270-w10.1038/s41467-020-17270-w ↗
72. 10.1073/pnas.080824910510.1073/pnas.0808249105 ↗
73. 10.1038/cdd.2010.6110.1038/cdd.2010.61 ↗
74. 10.1038/s41556-024-01544-210.1038/s41556-024-01544-2 ↗
75. 10.1038/s41467-024-51680-410.1038/s41467-024-51680-4 ↗
76. 10.2174/011566524027559423122912103010.2174/0115665240275594231229121030 ↗
77. 10.1016/j.mce.2016.06.00810.1016/j.mce.2016.06.008 ↗
78. 10.1523/JNEUROSCI.1357-09.200910.1523/JNEUROSCI.1357-09.2009 ↗
79. 10.1016/j.biopha.2023.11524710.1016/j.biopha.2023.115247 ↗
80. 10.3389/fnmol.2017.0038810.3389/fnmol.2017.00388 ↗
81. 10.1016/j.biopsych.2013.09.02210.1016/j.biopsych.2013.09.022 ↗
82. 10.1016/0896-6273(95)90092-610.1016/0896-6273(95)90092-6 ↗